Cardiovascular · 2022

FDA-cleared AI devices for cardiovascular 2022

2022 has 14 cardiovascular AI devices, 27.3% more than 2021 (11). That is 9.1% of the 154 cardiovascular devices on the FDA list, and 8.6% of all AI-device decisions dated 2022. The most active were AliveCor, Inc. (1), Apple Inc. (1), Avive Solutions, Inc. (1). The newest is STAR Apollo Mapping System from Rhythm Al, Ltd, decided on December 1, 2022.

142022 devices
14Companies
8.6%Of all 2022 AI devices
9.1%Of all cardiovascular

By month

Apr: 3May: 1Jun: 2Jul: 4Aug: 1Sep: 0Oct: 2Nov: 0Dec: 1
AprMayJunJulAugSepOctNovDec
Cardiovascular AI devices by month in 2022: Apr 3, May 1, Jun 2, Jul 4, Aug 1, Sep 0, Oct 2, Nov 0, Dec 1

All 14 devices

Frequently asked questions

How many FDA-cleared AI cardiovascular devices were there in 2022?

14 AI-enabled cardiovascular devices have a final decision dated 2022, from 14 companies.

How does 2022 compare with 2021 for AI cardiovascular devices?

2022 has 14 cardiovascular AI devices, 27.3% more than 2021 (11).

Which companies cleared the most AI cardiovascular devices in 2022?

AliveCor, Inc. (1), Apple Inc. (1), Avive Solutions, Inc. (1).

What was the most recent AI cardiovascular device in 2022?

STAR Apollo Mapping System from Rhythm Al, Ltd (K220786), decided on December 1, 2022. Product code DQK.

Which product codes were most common for AI cardiovascular devices in 2022?

DQK (Computer, Diagnostic, Programmable): 4; DQD (Stethoscope, Electronic): 2; PJA (Coronary Vascular Physiologic Simulation Software): 2.

Cite as: AI Device Radar, “FDA-cleared AI devices for cardiovascular 2022,” https://ai-device-radar.vercel.app/specialty/cardiovascular/2022 (FDA list through 2026-06-29).